Stock Ticker

  • Loading stock data...

QBioMed (QBIO): Counter Punching Glaucoma with Powerful Combinations

May 15, 2019 – WallstreetPR.com, the leading agency and financial media network dedicated to covering the biotech industry, announces the publication of an article covering QBioMed (QBIO) who is counter punching glaucoma with powerful combinations combating one of the leading causes of vision loss worldwide and the leading cause of irreversible blindness worldwide. Glaucoma is […]

3 Biotech Stocks to Watch: QBioMed Inc, Seattle Genetics and Jazz Pharmaceuticals

2018 turned out to be superb for the pharma and biotech sector with the FDA approval of 59 drugs compared to only 46 drugs approved in 2017. Some investors like the idea of stepping in small-cap biotech stocks that are in the development or preclinical stage, hoping to ride the next multi-baggers if those companies […]

Three Small-Cap Plays that Offer Some Bang for the Buck (CLVS, QBIO, BPMC)

The carnage in the biotech space in Q4 of last year was devastating to a lot of portfolios, and many of the stocks in the space became victims of aggressive tax-loss selling before year end to add insult to injury. But, rejoice, dear investor! That just means we have some great values lying around on […]

Sign Up To Get Our Latest Stocks Alerts